Nuzenio

Prostate Cancer Trial

Prostate Cancer Trial news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

SYNC-T Therapy SV-102 Shows Early Promise, Advances to Phase 2 LEGION-100 Trial in Refractory Prostate Cancer - OncLiveOncLive · Mon, 10 Aug 2026 12:11:30 GMTStudy identifies barriers to equitable pediatric cancer trial participation - news-medical.netnews-medical.net · Mon, 10 Aug 2026 03:02:00 GMTExploring the Rationale for 5-Alpha Reductase Inhibitors in Prostate Cancer Prevention and Active Surveillance - OncLiveOncLive · Fri, 07 Aug 2026 19:32:40 GMTRadiopharmaceutical may benefit patients with metastatic prostate cancer sooner - Medical XpressMedical Xpress · Fri, 07 Aug 2026 17:20:05 GMTFDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 00:45:35 GMTClarity Pharmaceuticals reports two more complete responses in prostate cancer trial - BiotechDispatchBiotechDispatch · Wed, 05 Aug 2026 09:32:35 GMTClarity Pharmaceuticals Says Two New Participants in Prostate Cancer Trial Achieve Complete Response; Shares Jump 14% - MoomooMoomoo · Wed, 05 Aug 2026 01:11:43 GMTTumor and Organ Dose Estimates from 177Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial - Journal of Nuclear MedicineJournal of Nuclear Medicine · Thu, 30 Jul 2026 19:18:14 GMT

Timeline

Mon, 10 Aug 2026 12:11:30 GMTSYNC-T Therapy SV-102 Shows Early Promise, Advances to Phase 2 LEGION-100 Trial in Refractory Prostate Cancer - OncLive
Mon, 10 Aug 2026 03:02:00 GMTStudy identifies barriers to equitable pediatric cancer trial participation - news-medical.net
Fri, 07 Aug 2026 19:32:40 GMTExploring the Rationale for 5-Alpha Reductase Inhibitors in Prostate Cancer Prevention and Active Surveillance - OncLive
Fri, 07 Aug 2026 17:20:05 GMTRadiopharmaceutical may benefit patients with metastatic prostate cancer sooner - Medical Xpress
Fri, 07 Aug 2026 00:45:35 GMTFDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer - Targeted Oncology
Wed, 05 Aug 2026 09:32:35 GMTClarity Pharmaceuticals reports two more complete responses in prostate cancer trial - BiotechDispatch

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Prostate Cancer Trial.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.